Back to search

Netherlands· NL-fb9fe154f271

Kostaive poeder voor dispersie voor injectie COVID-19 sa-mRNA-vaccin

A covid-19, rna-based vaccine product containing zapomeran, registered in Netherlands by Seqirus Netherlands B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedKostaive poeder voor dispersie voor i…ATCJ07BN01REGISTER NO.NL-fb9fe154f271PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ZAPOMERAN
Manufacturer
Seqirus Netherlands B.V.
Country
Netherlands (NL)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/24/1873

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Covid-19, rna-based vaccine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All covid-19, rna-based vaccine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kostaive
  • Liechtenstein · Kostaive
  • Norway · Kostaive

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9cbdd7e5-887f-4dc1-94ea-6121621ed062
GET /v1/drugs/9cbdd7e5-887f-4dc1-94ea-6121621ed062?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Dispersie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/kostaive-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Covid-19, RNA-based vaccine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp131625",
  "excipients": [
    "1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLEENGLYCOL-2000",
    "1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE",
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "CHOLESTEROL",
    "KALIUMSORBAAT (E 202)",
    "NATRIUMCHLORIDE",
    "PENTADECAAN-8-YL 4-(3-(DIMETHYLAMINO)PROPYLSULFANYLCARBONYL-(4-OXO-4-PENTADECAAN-8-YLOXYBUTYL)AMINO)BUTANOAAT",
    "POLOXAMEER 188",
    "SACCHAROSE",
    "TROMETAMOL"
  ],
  "substances": [
    "ZAPOMERAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2025/02/12",
  "procedure_number": "EMEA/H/C/006207",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/24/1873",
  "additional_monitoring": "Y"
}

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.